Journal
American journal of obstetrics and gynecology
Publication Date
11-1-2020
Volume
223
Issue
5
First Page
739.e1
Last Page
739.e13
Document Type
Open Access Publication
DOI
10.1016/j.ajog.2020.08.004
Rights and Permissions
Paidas MJ, Tita ATN, Macones GA, Saade GA, Ehrenkranz RA, Triche EW, Streisand JB, Lam GK, Magann EF, Lewis DF, Dombrowski MP, Werner EF, Branch DW, Habli MA, Grotegut CA, Silver RM, Longo SA, Amon E, Cleary KL, How HY, Novotny SR, Grobman WA, Whiteman VE, Wing DA, Scifres CM, Sibai BM. Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia. Am J Obstet Gynecol. 2020 Nov;223(5):739.e1-739.e13. doi.org/10.1016/j.ajog.2020.08.004. Copyright 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). https://doi.org/10.1016/j.ajog.2020.08.004
Recommended Citation
Paidas, Michael J; Macones, George A; and et al, "Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia." American journal of obstetrics and gynecology. 223, 5. 739.e1 - 739.e13. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11948
